Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Anthraquinone dérivé")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 1622

  • Page / 65
Export

Selection :

  • and

Spectroscopic studies of cutaneous photosensitizing agents. XV, Anthralin and its oxidation product 1,8-dyhydroxyanthraquinoneDABESTANI, R; HALL, R. D; SIK, R. H et al.Photochemistry and photobiology. 1990, Vol 52, Num 5, pp 961-971, issn 0031-8655Article

Alkylation of DNA by the new anticancer agent 3,6-diaziridinyl-2,5-bis(carboethoxyamino)-1,4-benzoquinone (AZQ) = Alkylation du DNA par le nouvel agent anticancéreux, le 3,6-diaziridinyl-2,5-bis(carboéthoxyamino)-1,4-benzoquinone (AZQ)CHEUNG LAM KING; SIN-KUEN WONG; TI LI LOO et al.European journal of cancer & clinical oncology. 1984, Vol 20, Num 2, pp 261-264, issn 0277-5379Article

Analysis of rhubarb anthraquinones and bianthrones by microemulsion electrokinetic chromatographySUN, Shao-Wen; YEH, Pei-Chen.Journal of pharmaceutical and biomedical analysis. 2005, Vol 36, Num 5, pp 995-1001, issn 0731-7085, 7 p.Article

Free radical formation from anthracycline antitumour. Agents and model systems. I: Model naphthoquinones and anthraquinonesDODD, N. J. F; MUKHERJEE, T.Biochemical pharmacology. 1984, Vol 33, Num 3, pp 379-385, issn 0006-2952Article

Chemotaxonomic significance of anthraquinone derivatives in North American species of Dermocybe, section SanguineaeKELLER, G; AMMIRATI, J. F.Mycotaxon. 1983, Vol 18, Num 2, pp 357-377, issn 0093-4666Article

NATURAL ANTHRAQUINONE DRUGSFAIRBAIRN JW ED.1980; PHARMACOLOGY; CHE; DA. 1980; VOL. 20; SUPPL. 1; PP. 1-134; BIBL. DISSEM.Conference Paper

THE ANTHRAQUINONE LAXATIVES. SYMPOSIUM. PROC.; BISSONE, LUGANO; 1975.1976; PHARMACOLOGY; SWITZ.; DA. 1976; VOL. 14; SUPPL. 1; PP. 1-105; BIBL. DISSEM.; ISBN 3805524269Conference Paper

A zwitterionic anthraquinone derivative : first zwitterionic DNA binding ligandTAKENAKA, S; IHARA, T; HAMANO, M et al.Journal of the Chemical Society. Chemical communications. 1990, Num 18, pp 1271-1273, issn 0022-4936Article

Disposition of mitoxantrone in cancer patientsALBERTS, D. S; YEI-MEI PENG; LEIGH, S et al.Cancer research (Baltimore). 1985, Vol 45, Num 4, pp 1879-1884, issn 0008-5472Article

Anaphylactic reactions to diaziquonePOSADA, J. G; ÓDWYER, P. J; HOTH, D. F et al.Cancer treatment reports. 1984, Vol 68, Num 10, pp 1215-1217, issn 0361-5960Article

BIOSYNTHETIC RELATIONSHIP BETWEEN TETRAHYDROANTHRACENE AND ANTHRAQUINONE IN ALOE SAPONARIA.YAGI A; YAMANOUCHI M; NISHIOKA I et al.1978; PHYTOCHEMISTRY; G.B.; DA. 1978; VOL. 17; NO 5; PP. 895-897; BIBL. 7 REF.Article

ISOLATION AND IDENTIFICATION OF ERYTHROGLAUCIN (1,4,5-TRIHYDROXY-7-METHOXY-2-METHYLANTHRAQUINONE) FROM THE MYCELIUM OF ALTERNARIA PORRI (ELLIS) CIFERRI.SUEMITSU R; IWAI J; KAWAGUCHI K et al.1977; AGRIC. BIOL. CHEM.; JAP.; DA. 1977; VOL. 41; NO 11; PP. 2289-2290; BIBL. 10 REF.Article

Biosynthesis of PD 116740 : origins of the carbon, hydrogen, and oxygen atoms and derivation from a 6-deoxybenz[a]anthraquinoneGOULD, S. J; XING-CHUN CHENG; MELVILLE, C et al.Journal of the American Chemical Society. 1994, Vol 116, Num 5, pp 1800-1804, issn 0002-7863Article

Clinical development of bisantrene: a novel anthracene derivative = Développement clinique du bisantrène: une nouvelle anthraquinoneMUGGIA, F. M; SPIEGEL, R. J; GAMS, R. A et al.Monograph series of the European Organization for Research on Treatment of Cancer. 1983, Vol 12, pp 175-182, issn 0146-0447Article

Comparative study of the photochromic properties of 1-aryloxyanthraquinones in polymeric filmsEROSHKIN, V. I; FOKIN, E. P; VOLKOV, A. I et al.Russian journal of physical chemistry. 1991, Vol 65, Num 6, pp 784-787, issn 0036-0244Article

Phase I study of a new anthraquinone derivative, mitoxantrone = Etude phase I d'une nouvelle anthraquinone, la mitoxantroneOGAWA, M; SAITO, T; WAKUI, A et al.Monograph series of the European Organization for Research on Treatment of Cancer. 1983, Vol 12, pp 85-91, issn 0146-0447Article

Synthesis of morindaparvin A, an antitumor agent, and related anthraquinonesKHANAPURE, S. P; BIEHL, E. R.Journal of natural products (Print). 1989, Vol 52, Num 6, pp 1357-1359, issn 0163-3864Article

Hypoglycemia: not an important side effect of mitoguazoneFOSTER, B. J; CLAGETT-CARR, K; O'DWYER, P. J et al.Cancer treatment reports. 1985, Vol 69, Num 11, issn 0361-5960, 1340Article

LES OXYMETHYL ANTHRAQUINONES DES ORGANES SOUTERRAINS DE RUMEX RECHINGERIANUS LOSINSKVYSOCHINA GI; GONTAR EH M.1976; RASTIT. RESURSY; S.S.S.R.; DA. 1976; VOL. 12; NO 3; PP. 394-397; BIBL. 11 REF.Article

Inhibition of growth, morphological and morphometrical changes induced by amido-anthraquinone derivatives in NCTC 2544 and HeLa cellsCONCONI, M. T; PARNIGOTTO, P. P; BONALI, A et al.ATLA. Alternatives to laboratory animals. 1992, Vol 20, Num 1, pp 84-94, issn 0261-1929Article

New black liquid-crystalline guest-host systems for indoor and outdoor applicationsSCHEUBLE, B. S; WEBER, G; POHL, L et al.Proceedings of the society for information display. 1984, Vol 25, Num 1, pp 25-30, issn 0734-1768Article

Measurement of iron(III) bioavailability in pure iron oxide minerals and soils using anthraquinone-2,6-disulfonate oxidationHACHERL, Eric L; KOSSON, David S; YOUNG, Lily Y et al.Environmental science & technology. 2001, Vol 35, Num 24, pp 4886-4893, issn 0013-936XArticle

Biosynthesis of dehydrorabeblomycin and PD 116740 : prearomatic deoxygenation as evidence for different polyketide synthases in the formation of benz[a]anthraquinonesGOULD, S. J; XING-CHUN CHENG; HALLEY, K. A et al.Journal of the American Chemical Society. 1992, Vol 114, Num 25, pp 10066-10068, issn 0002-7863Article

MitoxantronePOIRIER, T. I.Drug intelligence & clinical pharmacy. 1986, Vol 20, Num 2, pp 97-105, issn 0012-6578Article

Pharmacokinetics of diaziquone after three different dosage regimensBJORNSSON, T. D; SCHOLD, S. C; FRIEDMAN, H. S et al.Cancer treatment reports. 1985, Vol 69, Num 12, pp 1383-1385, issn 0361-5960Article

  • Page / 65